The advertisement promotes Fasenra (benralizumab) as an add-on treatment for patients aged 6 and older with severe eosinophilic asthma, emphasizing its safety information and contraindications.
Creative Information
| CID: | b39ab810-3fb5-435a-b279-daf6c040c950 |
| CRID: | 82_6988-947121 |
| Domain: | fasenrahcp.com |
| Seat: | PP |
| Size: | 160x600 |
| Bid: | $80.00 |
| Timestamp: | 11/7/2025, 2:25:43 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/7/2025, 2:42:52 PM | 9.05s | |
| adomain_analysis | success | 11/7/2025, 5:09:44 PM | 3.45s | |
| adomain_capture | success | 11/7/2025, 5:09:41 PM | 0.14s | |
| ad_render | success | 11/7/2025, 2:42:43 PM | 26.44s | |
| brand_mapping | success | 11/7/2025, 2:25:43 PM | 0.17s | |
Analysis Results
Ad Format: banner
Brands: FASENRA
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 160x600 | ||||||||||||||||||||||
| Data Transferred: | 1628.56 KB | ||||||||||||||||||||||
| Render Time: | 11.04 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1628.64 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


